Venture NAV Tracker / Private company
Nucleus RadioPharma, Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Equity & warrant marks
One latest disclosed mark per fund.
| Fund | Fair value | Security / basis | Implied price / share | Mark age vs round | Methodology / filing |
|---|---|---|---|---|---|
| TRINTrinity Capital Inc. | $22KMar 31, 2026 · source ↗ | warrantFair Value | $0.51Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | 10-Q 2026-03-31 ↗ |
Cross-fund comparison
Debt investments
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| TRINTrinity Capital Inc. | senior secured loanFair Value — Secured Loan | $1.2MMar 31, 2026 · source ↗ | $1.2MMar 31, 2026 · source ↗ | 102.2%Mar 31, 2026 · source ↗ | Fixed interest rate 12.0%; EOT 4.0%Mar 31, 2026 · source ↗ | Oct 1, 2028Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.